LEADER 02257oam  2200601   450 
001 9910703955203321
005 20160222145722.0
035   $a(CKB)5470000002436189
035   $a(OCoLC)920554241
035   $a(EXLCZ)995470000002436189
100   $a20150909d2015      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aExamining the 340B drug pricing program $ehearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, March 24, 2015
210  1$aWashington :$cU.S. Government Publishing Office,$d2015.
215   $a1 online resource (iii, 107 pages)
300   $aTitle from title screen (viewed on Sept. 9, 2015).
300   $aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
300   $a"Serial No. 114-25."
320   $aIncludes bibliographical references.
517   $aExamining the 340B drug pricing program 
606   $aPrescription pricing$xGovernment policy$zUnited States
606   $aPoor$xPharmaceutical assistance$zUnited States
606   $aOlder people$xPharmaceutical assistance$zUnited States
606   $aOlder people$xPharmaceutical assistance$2fast
606   $aPoor$xPharmaceutical assistance$2fast
606   $aPrescription pricing$xGovernment policy$2fast
607   $aUnited States$2fast
608   $aLegislative hearings.$2lcgft
608   $aLegislative hearings.$2fast
615  0$aPrescription pricing$xGovernment policy
615  0$aPoor$xPharmaceutical assistance
615  0$aOlder people$xPharmaceutical assistance
615  7$aOlder people$xPharmaceutical assistance.
615  7$aPoor$xPharmaceutical assistance.
615  7$aPrescription pricing$xGovernment policy.
801  0$bGPO
801  1$bGPO
801  2$bSTF
801  2$bOCLCO
801  2$bCOO
801  2$bOCLCO
801  2$bUBY
801  2$bOCLCO
801  2$bOCLCF
801  2$bGPO
906   $aBOOK
912   $a9910703955203321
996   $aExamining the 340B drug pricing program$93512925
997   $aUNINA